HIGHLIGHTS
- who: Cuilin Zhu from the Huazhong University of Science and Technology, China have published the research: Hydrogen sulfide: A new therapeutic target in vascular diseases, in the Journal: (JOURNAL)
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- future: Exploring the therapeutic potential in regulating vascular diseases will be promising in the near future. Future research should focus on the role and mechanism of H2S and different H2S releasing donors in treating vascular diseases . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.